1. CPM update for lenvatinib regarding pneumothorax risk

   News item 10 November 2018 Pages: 1 - 1

2. Japan PMDA's Relief System for ADRs: 5-year analysis

   News item 10 November 2018 Pages: 2 - 2

3. Package insert revisions for three therapies in Japan

   News item 10 November 2018 Pages: 3 - 3

4. Risk of aortic aneurysm and dissection with fluoroquinolones

   Correspondence 10 November 2018 Pages: 4 - 4

5. US FDA's efforts to tackle opioid-related deaths

   News item 10 November 2018 Pages: 5 - 5

6. Antibacterials, acid suppressants: risk of childhood obesity

   Clinical study 10 November 2018 Pages: 6 - 6

7. Clinical studies on cancer dugs downplay adverse events

   Clinical study 10 November 2018 Pages: 7 - 7

8. Genotype-guided fluoropyrimidine cancer therapy

   Clinical study 10 November 2018 Pages: 8 - 8

9. More healthcare utilisation and suicide with benzodiazepines

   Clinical study 10 November 2018 Pages: 9 - 9

10. Potential drug safety concerns in patients with cirrhosis

    Clinical study 10 November 2018 Pages: 10 - 10

11. Safety evaluation of infliximab originator and biosimilars

    Clinical study 10 November 2018 Pages: 11 - 11

12. Systematic review: shingles vaccination of older adults

    Clinical study 10 November 2018 Pages: 12 - 12

13. 17DD-yellow-fever-vaccine

    Case report 10 November 2018 Pages: 13 - 13

14. Abatacept

    Case report 10 November 2018 Pages: 14 - 14

15. Abciximab/alteplase/heparin

    Case report 10 November 2018 Pages: 15 - 15

16. Adalimumab

    Case report 10 November 2018 Pages: 16 - 16

17. Adalimumab

    Case report 10 November 2018 Pages: 17 - 17

18. Adalimumab/infliximab/thalidomide

    Case report 10 November 2018 Pages: 18 - 18

19. Adefovir

    Case report 10 November 2018 Pages: 19 - 19

20. Afatinib/cetuximab

    Case report 10 November 2018 Pages: 20 - 20

21. Allopurinol/mercaptopurine

    Case report 10 November 2018 Pages: 21 - 21

22. Amantadine

    Case report 10 November 2018 Pages: 22 - 22

23. Amantadine

    Case report 10 November 2018 Pages: 23 - 23

24. Amikacin/clofazimine

    Case report 10 November 2018 Pages: 24 - 24

25. Amiodarone/dabigatran etexilate/fluconazole interaction

    Case report 10 November 2018 Pages: 25 - 25

26. Amiodarone/fluconazole/valproic acid

    Case report 10 November 2018 Pages: 26 - 26

27. Amiodarone/itraconazole interaction

    Case report 10 November 2018 Pages: 27 - 27

28. Amlodipine

    Case report 10 November 2018 Pages: 28 - 28

29. Amlodipine/telmisartan overdose

    Case report 10 November 2018 Pages: 29 - 29

30. Amoxicillin/clavulanic acid/herbal medicines

    Case report 10 November 2018 Pages: 30 - 30

31. Amphotericin B/methylprednisolone

    Case report 10 November 2018 Pages: 31 - 31

32. Anti-neoplastics

    Case report 10 November 2018 Pages: 32 - 32

33. Antibacterials

    Case report 10 November 2018 Pages: 33 - 33

34. Antibacterials

    Case report 10 November 2018 Pages: 34 - 34

35. Antibacterials/antiepileptic drugs

    Case report 10 November 2018 Pages: 35 - 35

36. Antibiotics

    Case report 10 November 2018 Pages: 36 - 36

37. Antifungals

    Case report 10 November 2018 Pages: 37 - 37

38. Antihypertensives

    Case report 10 November 2018 Pages: 38 - 38

39. Antineoplastics

    Case report 10 November 2018 Pages: 39 - 39

40. Antineoplastics

    Case report 10 November 2018 Pages: 40 - 40

41. Antineoplastics

    Case report 10 November 2018 Pages: 41 - 41

42. Antineoplastics

    Case report 10 November 2018 Pages: 42 - 42

43. Antineoplastics

    Case report 10 November 2018 Pages: 43 - 43

44. Antineoplastics

    Case report 10 November 2018 Pages: 44 - 44

45. Antineoplastics

    Case report 10 November 2018 Pages: 45 - 45

46. Antineoplastics

    Case report 10 November 2018 Pages: 46 - 46

47. Antineoplastics/antipsoriatics

    Case report 10 November 2018 Pages: 47 - 47

48. Antineoplastics/melphalan

    Case report 10 November 2018 Pages: 48 - 48

49. Antipsychotics/promethazine

    Case report 10 November 2018 Pages: 49 - 49

50. Antituberculars

    Case report 10 November 2018 Pages: 50 - 50